Shoulder Innovations, Inc. (SI): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$36.02M
Year ended 2025-12-31
-$47.08M
Trailing 12 months to 2026-06-30
2024-12-31: -$18.16M2025-12-31: -$36.02M-$36.02M
2024-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$36.02Mn/m2026-03-10, From 2025-01-01
2024-12-31-$18.16Mn/a2026-03-10, From 2024-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Shoulder Innovations, Inc. (SI)2025-12-31-$36.02Mn/m
TriSalus Life Sciences, Inc. (TLSI)2025-12-31-$18.93Mn/m
Carlsmed, Inc. (CARL)2025-12-31-$29.62Mn/m
SANUWAVE Health, Inc. (SNWV)2025-12-31$1.93M-1.6%
SS Innovations International, Inc. (SSII)2025-12-31-$22.20Mn/m
Apyx Medical Corp (APYX)2025-12-31-$9.12Mn/m
KORU Medical Systems, Inc. (KRMD)2025-12-31-$470.1Kn/m
CVRx, Inc. (CVRX)2025-12-31-$40.75Mn/m
Interpace Biosciences, Inc. (IDXG)2025-12-31$5.47M+45.2%

Compare SI, TLSI, CARL, SNWV side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗